ADAG
Adagene Inc - ADR

244
Mkt Cap
$184.75M
Volume
10,605.00
52W High
$4.58
52W Low
$1.30
PE Ratio
-6.08
ADAG Fundamentals
Price
$3.80
Prev Close
$3.92
Open
$3.87
50D MA
$2.89
Beta
0.04
Avg. Volume
103,143.00
EPS (Annual)
-$0.7426
P/B
4.87
Rev/Employee
$748.23
$22.91
Loading...
Loading...
News
all
press releases
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Given Consensus Recommendation of "Buy" by Analysts
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) has been assigned a consensus rating of "Buy" from the five analysts that are currently covering the company, Marketbeat reports. One...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Adagene (NASDAQ:ADAG) Raised to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Adagene to a "hold" rating in a research report on Saturday...
MarketBeat·3d ago
News Placeholder
Adagene (ADAG) to Release Earnings on Monday
Adagene (NASDAQ:ADAG) will be releasing its Q4 2025 earnings before the market opens on Monday, March 23. (View Earnings Report at...
MarketBeat·8d ago
News Placeholder
Adagene Spotlights ADG126 at Leerink, Teases New MSS Colorectal Cancer Data Update Soon
Adagene (NASDAQ:ADAG) outlined its clinical and strategic priorities at Leerink Partners' global healthcare conference, with Chief Strategy Officer Mickael Chane-Du focusing primarily on the...
MarketBeat·15d ago
News Placeholder
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Short Interest Down 24.5% in February
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) saw a large decline in short interest during the month of February. As of February 13th, there was short interest totaling 47,428 shares, a...
MarketBeat·22d ago
News Placeholder
Adagene Spotlights ADG126+KEYTRUDA Data, Late-Line MSS-CRC Focus in Oppenheimer Conference Talk
Adagene (NASDAQ:ADAG) highlighted updated details around its lead immuno-oncology program, ADG126, during an Oppenheimer discussion featuring Chief Strategy Officer Mickael Chane-Du. The company is...
MarketBeat·27d ago
News Placeholder
Moderna's Shares Climb 5.3% as Investors Revisit Biotech Leaders
MRNA shares jumped 5.3% as investors rotated into large-cap biotech, betting on its expanding pipeline in volatile trade.
Zacks·1mo ago
News Placeholder
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Expands By 283.2%
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the recipient of a large increase in short interest in January. As of January 30th, there was short interest totaling 62,815 shares, an...
MarketBeat·1mo ago
News Placeholder
Short Interest in Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Drops By 31.1%
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) was the target of a large decrease in short interest in the month of January. As of January 15th, there was short interest totaling 16,394...
MarketBeat·2mo ago
News Placeholder
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) have received an average recommendation of "Moderate Buy" from the six brokerages that are currently covering the firm...
MarketBeat·2mo ago
<
1
2
...
>

Latest ADAG News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.